Pharmaceutical Analytical and Interventional study of Darvyadi Granules in Iron Deficiency Anaemia-A Pilot Study
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- 1.New modifieddosage form of Darvyadi Churna will be introducedin clinical practice which will be suitable for all age groups from paediatric to Geriatric.
研究概览
简要总结
Anaemia is a major public health concern in India and20% of the population suffer globally. The major cause of the disease isrecognized as Iron deficiency. In the present project objective of the study willbe to evaluate the efficacy of Darvyadi Granules in Iron deficiency anaemia inhuman subjects. In Panduroga Rogadhikaraof Charak Samhita, Darvyadi churna is mentioned which is indicated in YakritVikara and Panduroga. It includes 9 ingradients namely Triphala, Trikatu,Darvi, Vidanga and Lauha Bhasma. In the present work this formulation ismodified to Darvyadi Granules for better acceptability and palatability to thepatients. Darvyadi Granules will be prepared in the teaching Pharmacy, PIAR.Raw materials and final product quality assessment will be done in recognizedanalytical laboratories.
Itis an open labeled single centric clinical trial.As it isa pilot study, sample size of 30 subjects irrespective of race, gender,occupation, socio economic status will be considered. The subjective parameterssuch as Pallor,Shortnessof Breath, Fatigue, Palpitation, and Dizziness will be assessed. Hb%, Complete Blood Count, SerumFerritin, Total Iron Binding Capacityand PeripheralSmear of the patient will be investigated to observe the effect. Patients willbe screened for the study based on subjective parameters Hb% and MCV. Patientswill be on treatment with trial drug for a period of 3 months and observationwill be done on every 15th day. The duration of the project will be18 months which includes preparation of the medicine, screening of the patientsand treatment period of 90 days. The observations will be statisticallyanalyzed and documented.
研究设计
- 研究类型
- Interventional
- 分配方式
- Not Applicable
- 盲法
- Not Applicable
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •Patient fulfilling screening parameters. Age limit 18-70 years irrespective of religion, socioeconomic, marital status and gender Hb%.
- •Between 8 gm% and 11gm%.
排除标准
- •Anemia other than Iron deficiency anemia, Sickle cell anemia.
- •Patients suffering from systemic disorders like tuberculosis, HIV, Leprosy and any malignancies.
- •Pregnant and Lactating Woman.
结局指标
主要结局
1.New modifieddosage form of Darvyadi Churna will be introducedin clinical practice which will be suitable for all age groups from paediatric to Geriatric.
时间窗: 1 year
3.The study may throw up effective remedy for treating Iron Deficiency Anaemia thus benefiting the population suffering from the disease.
时间窗: 1 year
2.This particular form of medicine is not available and is also cost effective.
时间窗: 1 year
次要结局
- 2.This particular form of medicine is not available and is also cost effective.(3.The study may throw up effective remedy for treating Iron Deficiency Anaemia thus benefiting the population suffering from the disease.)
